319 related articles for article (PubMed ID: 31232712)
21. [Sodium bicarbonate to slow the progression of chronic kidney disease].
Rossier A; Bullani R; Burnier M; Teta D
Rev Med Suisse; 2011 Mar; 7(284):478-82. PubMed ID: 21462516
[TBL] [Abstract][Full Text] [Related]
22. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study.
Di Iorio B; Aucella F; Conte G; Cupisti A; Santoro D
J Nephrol; 2012; 25(3):437-40. PubMed ID: 21928233
[TBL] [Abstract][Full Text] [Related]
23. Metabolic Acidosis in CKD: A Review of Recent Findings.
Melamed ML; Raphael KL
Kidney Med; 2021; 3(2):267-277. PubMed ID: 33851122
[TBL] [Abstract][Full Text] [Related]
24. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
[TBL] [Abstract][Full Text] [Related]
25. The effect of sodium bicarbonate on cytokine secretion in CKD patients with metabolic acidosis.
Ori Y; Zingerman B; Bergman M; Bessler H; Salman H
Biomed Pharmacother; 2015 Apr; 71():98-101. PubMed ID: 25960222
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of Veverimer in the Treatment of Metabolic Acidosis Caused by Chronic Kidney Disease: A Meta-analysis.
Liu W; Li L; Zhang X; Dong H; Lu M
Front Pharmacol; 2021; 12():643128. PubMed ID: 33995050
[TBL] [Abstract][Full Text] [Related]
27. Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment.
Adamczak M; Surma S
Kidney Dis (Basel); 2021 Nov; 7(6):452-467. PubMed ID: 34901192
[TBL] [Abstract][Full Text] [Related]
28. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
Trials; 2015 Aug; 16():326. PubMed ID: 26231610
[TBL] [Abstract][Full Text] [Related]
29. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
Bushinsky DA
Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
[TBL] [Abstract][Full Text] [Related]
30. Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences.
Fernandez-Prado R; Villalvazo P; Avello A; Gonzalez-de-Rivera M; Aguirre M; Carrasco-Muñoz CG; Fernandez-Fernandez B; Martin-Cleary C; Carriazo S; Sanchez-Niño MD; Perez-Gomez MV; Ortiz A
Biomed Pharmacother; 2023 Feb; 158():114197. PubMed ID: 36916426
[TBL] [Abstract][Full Text] [Related]
31. Effect of oral alkali supplementation on progression of chronic kidney disease.
Gaggl M; Sliber C; Sunder-Plassmann G
Curr Hypertens Rev; 2014; 10(2):112-20. PubMed ID: 25549843
[TBL] [Abstract][Full Text] [Related]
32. Oral sodium bicarbonate improves thyroid function in predialysis chronic kidney disease.
Disthabanchong S; Treeruttanawanich A
Am J Nephrol; 2010; 32(6):549-56. PubMed ID: 21042013
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Acidosis in CKD: Core Curriculum 2019.
Raphael KL
Am J Kidney Dis; 2019 Aug; 74(2):263-275. PubMed ID: 31036389
[TBL] [Abstract][Full Text] [Related]
34. Acidosis: progression of chronic kidney disease and quality of life.
de-Brito Ashurst I; O'Lone E; Kaushik T; McCafferty K; Yaqoob MM
Pediatr Nephrol; 2015 Jun; 30(6):873-9. PubMed ID: 25085611
[TBL] [Abstract][Full Text] [Related]
35. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.
Bellasi A; Di Micco L; Santoro D; Marzocco S; De Simone E; Cozzolino M; Di Lullo L; Guastaferro P; Di Iorio B;
BMC Nephrol; 2016 Oct; 17(1):158. PubMed ID: 27770799
[TBL] [Abstract][Full Text] [Related]
36. Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease.
Goraya N; Wesson DE
Curr Opin Nephrol Hypertens; 2019 May; 28(3):267-277. PubMed ID: 30681417
[TBL] [Abstract][Full Text] [Related]
37. Sodium citrate versus sodium bicarbonate for metabolic acidosis in patients with chronic kidney disease: A randomized controlled trial.
Sorohan BM; Obrișcă B; Jurubiță R; Lupușoru G; Achim C; Andronesi A; Frățilă G; Berechet A; Micu G; Ismail G
Medicine (Baltimore); 2024 Mar; 103(10):e37475. PubMed ID: 38457574
[TBL] [Abstract][Full Text] [Related]
38. Correction of chronic metabolic acidosis for chronic kidney disease patients.
Roderick P; Willis NS; Blakeley S; Jones C; Tomson C
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001890. PubMed ID: 17253467
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD.
Raphael KL
J Am Soc Nephrol; 2018 Feb; 29(2):376-382. PubMed ID: 29030467
[TBL] [Abstract][Full Text] [Related]
40. Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial.
Mathur RP; Dash SC; Gupta N; Prakash S; Saxena S; Bhowmik D
Ren Fail; 2006; 28(1):1-5. PubMed ID: 16526312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
